PGM-1 is essential to address glucose to glycogen synthesis; thus, a reduction in PGM-1 levels in CRC cells could stimulate cellular proliferation and tumor growth by enhancing the glycolytic pathway as previously proposed [34]. The gene discussed is PGM1; the disease is neoplasm.